Neurocognitive Disorders

65 questions

Question 41Question →

Match each clinical vignette with the most likely underlying neurocognitive diagnosis.

Click a left item, then click its matching right item

Items

A 73-year-old woman experiences an insidious, progressive decline in her short-term memory over three years, initially struggling to recall recent conversations, with no focal motor deficits on examination.
A 59-year-old woman exhibits socially inappropriate behavior, profound apathy, and diminished hygiene over the past year, while her performance on spatial and memory tasks remains relatively intact.
A 68-year-old man presents with well-formed visual hallucinations of children playing in his room, fluctuating periods of confusion, and resting tremor with rigidity in his upper extremities.
A 76-year-old man has a history of multiple transient ischemic attacks and now presents with a stepwise deterioration in executive functioning and asymmetric deep tendon reflexes.
A 78-year-old man develops a slow, wide-based, shuffling gait, new-onset urinary incontinence, and slowed mentation without prominent cortical signs.

Matches

Show answer & explanation

Answer

The correct matches align each clinical vignette with its signature presentation: the patient with insidious memory loss has Alzheimer disease, the patient with behavioral changes has frontotemporal dementia, the patient with hallucinations and parkinsonism has Lewy body dementia, the patient with stepwise decline has vascular dementia, and the patient with gait impairment and incontinence has normal pressure hydrocephalus.
Each neurocognitive disorder has a distinct clinical signature. Alzheimer disease classically presents with insidious, progressive memory loss. Frontotemporal dementia features early behavioral and personality changes. Lewy body dementia is characterized by recurrent visual hallucinations, fluctuating alertness, and parkinsonism. Vascular dementia follows a stepwise decline temporally related to cerebrovascular events, often with focal neurologic deficits. Normal pressure hydrocephalus presents with the characteristic triad of magnetic gait, incontinence, and cognitive slowing.

Step-by-Step Solution

1
Analyze the clinical vignette for the 73-year-old woman.
Identified insidious short-term memory loss without focal signs.
To differentiate the most common cause of dementia, Alzheimer disease, from other etiologies.
2
Evaluate the 59-year-old woman's symptoms.
Noted early behavioral changes and apathy with spared memory.
These are hallmark features of frontotemporal dementia, distinguishing it from memory-first presentations.
3
Examine the 68-year-old man's presentation.
Recognized visual hallucinations, fluctuating cognition, and parkinsonism.
These form the core clinical criteria for Lewy body dementia.
4
Assess the 76-year-old man's history and exam.
Identified stepwise decline and asymmetric reflexes.
Indicative of multiple cerebral infarctions leading to vascular dementia.
5
Review the 78-year-old man's symptoms.
Found the triad of abnormal gait, incontinence, and cognitive slowing.
This triad is characteristic of normal pressure hydrocephalus, a potentially reversible cause of cognitive impairment.

Key Concept

Differential Diagnosis of Major Neurocognitive Disorders
Estimated Time:2m 0s
Question 42Question →

Match each clinical vignette describing a patient with progressive cognitive decline to the most likely underlying neurocognitive disorder diagnosis.

Click a left item, then click its matching right item

Items

A 55-year-old executive is fired after repeatedly making inappropriate sexual comments to subordinates. At home, she has become increasingly apathetic, neglects her personal hygiene, and obsessively consumes large quantities of candy. Her orientation and episodic memory are relatively preserved.
A 68-year-old mechanic exhibits severe, unpredictable fluctuations in daytime alertness and attention. His wife notes he frequently thrashes, punches, and yells while sleeping. Neurologic examination reveals cogwheel rigidity and bradykinesia, but no focal weakness.
A 72-year-old woman with poorly controlled diabetes and atrial fibrillation presents with prominent executive dysfunction and reduced processing speed. Her family reports her cognitive abilities worsened abruptly three months ago and have since plateaued. Exam shows an asymmetric Babinski sign.
A 75-year-old man presents with a 6-month history of a broad-based gait, describing his feet as feeling 'stuck to the floor.' He has recently developed pronounced psychomotor retardation, apathy, and episodes of urinary incontinence of which he seems unaware.

Matches

Show answer & explanation

Answer

Vignette 1 matches Frontotemporal neurocognitive disorder. Vignette 2 matches Major neurocognitive disorder with Lewy bodies. Vignette 3 matches Major vascular neurocognitive disorder. Vignette 4 matches Neurocognitive disorder due to normal pressure hydrocephalus.
Each major neurocognitive disorder has highly specific hallmark features during its early stages. Frontotemporal dementia (behavioral variant) targets the frontal lobes first, leading to profound personality shifts, hyperorality, and executive dysfunction before memory is significantly affected. Lewy body dementia is distinguished by the triad of fluctuating cognition, spontaneous parkinsonism, and complex visual hallucinations, frequently heralded by REM sleep behavior disorder. Vascular dementia relies on evidence of cerebrovascular disease, manifesting clinically as stepwise drops in cognition and focal neurologic deficits. Normal pressure hydrocephalus presents with a unique, potentially reversible triad of gait apraxia, urinary incontinence, and dementia.

Step-by-Step Solution

1
Analyze Vignette 1 for key distinguishing features.
Identified early disinhibition, apathy, and hyperorality with spared memory.
These are the diagnostic criteria for behavioral variant frontotemporal dementia.
2
Analyze Vignette 2 for specific neurologic and sleep abnormalities.
Identified REM sleep behavior disorder, fluctuating cognition, and parkinsonism.
These form the core clinical criteria required for diagnosing major neurocognitive disorder with Lewy bodies.
3
Evaluate Vignette 3 for temporal onset and associated risk factors.
Identified a stepwise cognitive decline temporally related to a presumed vascular event, confirmed by asymmetric upper motor neuron signs.
Abrupt deterioration followed by plateaus in a patient with severe cardiovascular risk factors indicates vascular dementia.
4
Examine Vignette 4 for syndromic triads.
Identified the Hakim-Adams triad: magnetic gait, urinary incontinence, and cognitive decline.
This specific combination of symptoms warrants evaluation for normal pressure hydrocephalus rather than primary neurodegenerative disorders.

Key Concept

Differentiating major neurocognitive disorders based on distinct initial clinical presentations, behavioral changes, temporal progression, and associated neurologic deficits.
Question 43Question →

An internal medicine physician is evaluating a 76-year-old male patient who presents with his daughter due to concerns about his worsening memory and unusual behavior over the past 14 months. The daughter reports that his cognitive abilities fluctuate drastically; on some days he is highly conversational and independent, while on other days he stares blankly for hours and requires help with dressing. He frequently reports seeing "small animals" hiding in the corners of his room. His medical history includes hypertension, benign prostatic hyperplasia, and Bipolar I disorder. He discontinued his mood stabilizer 5 years ago against medical advice but has remained euthymic since. Current medications include amlodipine, tamsulosin, and carbidopa-levodopa, which was initiated two months ago by a neurologist for a newly developed resting tremor and bradykinesia.

The patient's daughter is his legally appointed healthcare proxy via a verified advance directive. However, his estranged son is also present at the visit and demands that the physician immediately prescribe a strong medication to "stop the crazy visions," explicitly overriding his sister's request for a cautious approach.

On mental status examination, the patient is alert but oriented only to person. He scores 19/3019/30 on the Montreal Cognitive Assessment, with pronounced deficits in visuospatial function and executive tasks. Physical examination reveals bilateral cogwheel rigidity in the upper extremities.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate a cholinesterase inhibitor and discuss the disease trajectory with the daughter

Answer

Initiate a cholinesterase inhibitor and discuss the disease trajectory with the daughter
The correct answer synthesizes three critical elements of this case. First, the clinical triad of fluctuating cognition, well-formed visual hallucinations, and spontaneous parkinsonism establishes the diagnosis of Major Neurocognitive Disorder with Lewy Bodies (DLB). Second, the standard of care for initial pharmacologic management of both cognitive and neuropsychiatric symptoms in DLB is a cholinesterase inhibitor (e.g., rivastigmine or donepezil). Third, from an ethical standpoint, the physician must legally defer to the patient's daughter, as she is the designated healthcare proxy, and disregard the conflicting demands of the estranged son.

Step-by-Step Solution

1
Analyze the patient's clinical signs and timeline.
Identified a 14-month history of fluctuating cognition, complex visual hallucinations, and spontaneous parkinsonism (rigidity, tremor).
These three core features definitively meet the diagnostic criteria for Major Neurocognitive Disorder with Lewy Bodies (DLB).
2
Evaluate the ethical dilemma regarding surrogate decision-making.
Identified that the daughter is the legally appointed healthcare proxy via an advance directive.
Legally designated proxies have priority over all other next-of-kin, meaning the son's demands must be ethically overridden.
3
Determine the optimal pharmacologic management for DLB while avoiding contraindicated therapies.
Selected a cholinesterase inhibitor while avoiding typical antipsychotics and inappropriate SSRI monotherapy.
Cholinesterase inhibitors treat both the cognitive and behavioral symptoms in DLB safely, whereas neuroleptics trigger severe sensitivity reactions and SSRI monotherapy risks manic switch in bipolar history.

Key Concept

Diagnosis and management of Major Neurocognitive Disorder with Lewy Bodies (DLB), including surrogate decision-making ethics.
Estimated Time:2m 0s
Question 44Question →

A 78-year-old man is hospitalized for community-acquired pneumonia. On the evening of hospital day 3, he becomes acutely confused, agitated, and combative towards nursing staff. He attempts to pull out his intravenous line, claiming that "snakes are biting his arm." His baseline cognitive function is intact. Arrange the following interventions for managing this patient's acute agitation in the correct escalating sequence, from the initial preferred approach to the absolute last resort.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing this patient's acute agitation is: 1) Verbal de-escalation, 2) Rapid bedside medical assessment, 3) Sustained non-pharmacologic environmental adjustments, 4) Low-dose typical antipsychotic administration, and 5) Physical restraints.
Delirium is an acute, fluctuating neurocognitive disorder often triggered by underlying medical conditions. The management of associated agitation requires a stepwise escalation. The physician must first attempt to establish safety via verbal de-escalation. Immediately following this, identifying and reversing the underlying medical trigger (e.g., checking oxygen saturation, blood glucose, or examining for urinary retention) is critical. Sustained non-pharmacologic interventions, such as 1:1 sitters, reorientation, and sleep-wake cycle preservation, form the standard of care for symptom management. If these conservative measures fail and the patient remains an imminent danger to themselves or others, chemical restraints (e.g., low-dose haloperidol) may be utilized. Physical restraints are the most restrictive option; they can exacerbate delirium and cause physical injury, so they are indicated only as an absolute last resort to protect life-sustaining medical equipment.

Step-by-Step Solution

1
Attempt verbal de-escalation and behavioral redirection.
Establishes initial rapport and aims to quickly calm the patient without restrictive measures.
It is the least restrictive and most immediate bedside intervention available when encountering an agitated patient.
2
Perform a rapid bedside medical assessment.
Identifies rapidly reversible physiological triggers such as hypoxia, hypoglycemia, or acute pain.
Delirium is a manifestation of an underlying physiologic insult; correcting the medical trigger is the definitive treatment.
3
Institute sustained non-pharmacologic adjustments and assign a 1:1 sitter.
Provides continuous behavioral monitoring and a soothing, reorienting environment.
Non-pharmacologic measures are the standard of care for managing ongoing delirium symptoms without adverse drug effects.
4
Administer a low-dose typical antipsychotic.
Provides chemical restraint to safely manage severe, refractory agitation.
This is indicated only when behavioral measures fail and the patient poses an imminent physical threat to safety.
5
Apply physical restraints.
Physically prevents the patient from pulling out life-sustaining intravenous lines.
This is the most restrictive measure, carrying a high risk of worsening delirium, and must be used strictly as a last resort.

Key Concept

The management of delirium-associated agitation follows a strict, stepwise escalation pathway from least to most restrictive interventions.
Question 45Question →

An 82-year-old retired pilot is currently admitted to the surgical ward on post-operative day three following an open reduction and internal fixation of a right femoral neck fracture. The on-call physician is paged urgently by the nursing staff because the patient has suddenly become highly disoriented, verbally aggressive, and is actively attempting to remove his peripheral intravenous catheter and surgical dressings. His baseline cognitive status prior to admission was completely intact.

Arrange the following clinical actions in the most appropriate sequential order for the evaluation and management of this patient's acute behavioral decompensation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with ruling out immediate life threats (vitals/glucose), followed by implementing non-pharmacologic safety measures, reviewing medications, ordering targeted diagnostic labs, and finally, reserving antipsychotic medications strictly as a last resort.
The evaluation and management of acute delirium follows a strict, step-wise clinical algorithm designed to maximize patient safety and accurately identify reversible causes. The absolute first priority is evaluating ABCs (airway, breathing, circulation) and ruling out immediate life threats such as hypoxia or hypoglycemia via vital signs and point-of-care testing. Once life threats are excluded, the immediate goal is to safely manage the patient's agitation; this is achieved through first-line non-pharmacologic interventions like verbal de-escalation, reorientation, and continuous behavioral observation to prevent the patient from pulling lines. Subsequently, the physician must search for the underlying etiology. Reviewing the patient's medication list to identify and discontinue deliriogenic drugs (e.g., sedative-hypnotics, excessive opioids, anticholinergics) is a crucial early step, as iatrogenic causes are highly prevalent and easily modifiable. This is followed by ordering targeted diagnostic studies (e.g., comprehensive metabolic panel, urinalysis) to identify occult medical triggers like infections or electrolyte derangements. Finally, pharmacologic interventions such as low-dose haloperidol are reserved strictly as an intervention of last resort. They are indicated only when optimized non-pharmacologic measures have failed and the patient's severe agitation poses an imminent risk of physical harm to themselves or healthcare staff.

Step-by-Step Solution

1
Assess for immediate life-threatening causes.
Perform a rapid bedside assessment including vital signs, oxygen saturation, and point-of-care blood glucose.
Acute altered mental status requires immediate evaluation to exclude rapidly fatal and reversible causes like hypoxia or hypoglycemia.
2
Manage acute agitation safely at the bedside.
Implement non-pharmacologic safety measures (e.g., reorientation, 1:1 sitter).
First-line management for delirium-associated agitation focuses on de-escalation and environmental modification to avoid physical or chemical restraints.
3
Identify easily modifiable iatrogenic triggers.
Review the medication profile and discontinue deliriogenic agents.
Medications (e.g., opioids, anticholinergics) are the most common modifiable risk factors for inpatient delirium and should be stopped early in the evaluation.
4
Investigate underlying medical etiologies.
Order targeted laboratory studies (e.g., urinalysis, comprehensive metabolic panel).
A medical workup is necessary to identify other common triggers of delirium, such as urinary tract infections, metabolic encephalopathy, or electrolyte imbalances.
5
Utilize pharmacologic restraints only if strictly necessary.
Administer a low-dose antipsychotic (e.g., haloperidol).
Antipsychotics increase mortality in the elderly and are reserved only for severe agitation that poses an imminent physical danger to the patient or staff when all other measures fail.

Key Concept

The management of acute delirium prioritizes the exclusion of immediate life-threatening conditions, followed by non-pharmacologic de-escalation, identification and removal of iatrogenic triggers, targeted medical workup, and restricts the use of antipsychotics to a last-resort intervention.
Question 46Question →

An 81-year-old retired teacher is accompanied to the outpatient geriatrics clinic by her daughter. The daughter reports that over the past six to nine months, the patient has become increasingly forgetful and struggles to plan her usual weekly garden club meetings. Furthermore, the patient has recently stopped visiting her friends because she is embarrassed by frequent episodes of urinary incontinence. When asked about her mobility, the patient states, 'My feet feel like they are stuck to the ground.' Medical history is significant for well-controlled type 2 diabetes mellitus and mild osteoarthritis. Vital signs are within normal limits. Neurologic examination reveals a wide-based, slow, shuffling gait, but there is no resting tremor, cogwheel rigidity, or bradykinesia of the upper extremities. Cognitive testing reveals prominent deficits in executive function and attention. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Normal pressure hydrocephalus

Answer

The most likely diagnosis is Normal pressure hydrocephalus.
The correct answer is Normal pressure hydrocephalus (NPH). NPH is a potentially reversible cause of dementia characterized by the classic clinical triad of abnormal gait (described as magnetic, wide-based, or shuffling), urinary incontinence, and cognitive decline (particularly prominent executive dysfunction and psychomotor slowing). The gait abnormality is typically the first symptom to appear. The underlying pathophysiology involves decreased absorption of cerebrospinal fluid at the arachnoid granulations, leading to ventriculomegaly. The enlarged ventricles stretch the descending cortical fibers of the corona radiata, particularly those controlling leg movement and bladder function, resulting in the characteristic symptoms.

Step-by-Step Solution

1
Analyze the patient's presenting clinical symptoms and their timeline.
The patient exhibits a triad of cognitive decline (executive dysfunction), urinary incontinence, and a 'glued to the ground' magnetic gait developing over several months.
Identifying the specific symptom cluster is crucial for distinguishing between various major neurocognitive disorders.
2
Evaluate the neurologic examination findings to rule out related differentials.
The absence of resting tremor, cogwheel rigidity, and upper extremity bradykinesia makes Parkinson disease dementia and Dementia with Lewy bodies highly unlikely.
Gait abnormalities can be seen in multiple disorders, but the specific pattern (magnetic gait without upper body parkinsonism) isolates the pathology.
3
Synthesize the findings to establish the underlying etiology.
The clinical picture strongly points to Normal pressure hydrocephalus, caused by decreased cerebrospinal fluid absorption leading to enlarged ventricles that stretch the corona radiata.
The triad of 'wacky, wet, and wobbly' is the hallmark presentation of this potentially reversible condition.

Key Concept

Normal pressure hydrocephalus presents with the classic clinical triad of gait apraxia (magnetic gait), urinary incontinence, and cognitive decline (dementia), and is characterized by enlarged ventricles out of proportion to sulcal enlargement.
Question 47Question →

Match each distinct clinical presentation with the most likely underlying neurocognitive etiology.

Click a left item, then click its matching right item

Items

Recurrent, well-formed visual hallucinations, fluctuating cognition, and spontaneous features of parkinsonism.
Prominent changes in personality, behavioral disinhibition, hyperorality, and relative sparing of memory in the early stages.
Stepwise cognitive decline, prominent executive dysfunction, and evidence of focal neurological deficits on examination.
Rapidly progressive dementia over weeks to months, accompanied by startle myoclonus and periodic sharp wave complexes on EEG.

Matches

Show answer & explanation

Answer

The clinical presentations map to their respective etiologies based on core diagnostic features: hallucinations and parkinsonism match with Lewy body disease; behavioral changes and hyperorality match with frontotemporal dementia; stepwise decline matches with vascular dementia; and rapid progression with myoclonus matches with Creutzfeldt-Jakob disease.
Each neurocognitive disorder presents with a distinct constellation of early symptoms and temporal progression patterns that allow for accurate clinical differentiation prior to neuropathological examination.

Step-by-Step Solution

1
Evaluate the presentation featuring visual hallucinations, fluctuating cognition, and parkinsonism.
This maps to Major neurocognitive disorder with Lewy bodies.
These three symptoms constitute the core clinical criteria required for the diagnosis of Dementia with Lewy bodies.
2
Evaluate the presentation featuring early personality changes, disinhibition, and hyperorality.
This maps to Frontotemporal neurocognitive disorder.
These are the hallmark behavioral symptoms of the behavioral variant of frontotemporal dementia (Pick disease).
3
Evaluate the presentation featuring a stepwise cognitive decline and focal neurological deficits.
This maps to Vascular neurocognitive disorder.
Stepwise decline is characteristic of multi-infarct dementia, where each new microvascular or macrovascular event causes an abrupt drop in cognitive function.
4
Evaluate the presentation featuring rapid progression over weeks to months, accompanied by myoclonus.
This maps to Creutzfeldt-Jakob disease.
The extremely rapid timeline and the presence of startle myoclonus, confirmed by sharp waves on EEG, are classic pathognomonic signs of this prion disease.

Key Concept

Differentiating major neurocognitive disorders based on core clinical features and temporal progression.
Question 48Question →

A 74-year-old man with a 9-year history of Parkinson disease and emerging cognitive decline is brought to the emergency department by his daughter due to acute-onset, severe agitation and frightening visual hallucinations over the past 48 hours. He states that strangers are hiding in his room. His current medication regimen includes carbidopa-levodopa, pramipexole, and trihexyphenidyl. Arrange the following steps in the correct clinical escalation sequence for the evaluation and management of this patient's acute neuropsychiatric presentation, moving from initial assessment to therapies for refractory symptoms.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing acute psychosis and agitation in a patient with Parkinson disease or Lewy body dementia is: (1) medical evaluation for secondary causes, (2) discontinuation of anticholinergics, (3) discontinuation of dopamine agonists, (4) addition of a safe atypical antipsychotic like quetiapine, and finally (5) clozapine for refractory cases.
The management of acute behavioral changes and psychosis in patients with Parkinson disease or Lewy body dementia follows a strict, stepwise algorithm designed to balance psychiatric symptom control with the preservation of motor function. The essential first step is always to rule out an acute delirium secondary to a systemic illness. Once a systemic etiology is excluded, the existing medication regimen must be systematically simplified to eliminate medications that contribute most heavily to psychosis while providing the least critical motor benefit. Anticholinergic drugs (like trihexyphenidyl) are notoriously deliriogenic and are stopped first. Next, dopamine agonists (like pramipexole) are tapered off. Carbidopa-levodopa is maintained at the lowest effective dose because it is the most critical agent for motor function. If hallucinations persist despite this optimization, targeted pharmacotherapy is indicated. Only atypical antipsychotics with very low affinity for the dopamine D2 receptor (specifically quetiapine, pimavanserin, or clozapine) should be used, as other antipsychotics will induce severe parkinsonian rigidity. Quetiapine or pimavanserin are first-line choices. Clozapine is highly effective but is reserved for refractory cases due to the risk of agranulocytosis and the logistical burden of mandatory neutrophil monitoring.

Step-by-Step Solution

1
Evaluate for Delirium
Identifies or excludes systemic triggers
Acute behavioral changes in neurocognitive disorders are frequently driven by underlying infections or metabolic issues that require immediate medical treatment.
2
Optimize existing medications by withdrawing the most deliriogenic agents
Discontinues trihexyphenidyl
Anticholinergics provide minimal motor benefit in advanced disease but carry a massive risk for delirium and visual hallucinations.
3
Further simplify the dopaminergic regimen
Discontinues pramipexole
Dopamine agonists are the next most likely culprits for psychosis. Levodopa is spared as long as possible to preserve motor function.
4
Introduce targeted psychiatric symptom control
Initiates quetiapine or pimavanserin
Standard antipsychotics will severely worsen parkinsonism. Low D2-affinity agents are required to treat hallucinations safely.
5
Escalate to the treatment of last resort
Initiates clozapine
Used only when other safe antipsychotics fail, due to the burdensome requirement for absolute neutrophil count monitoring to prevent agranulocytosis.

Key Concept

Management algorithm for psychosis and delirium in Major Neurocognitive Disorder due to Parkinson Disease
Question 49Question →

A 7575-year-old man is brought to the clinic by his daughter due to a progressive decline in his mobility and memory over the past 88 months. The daughter reports that he has become increasingly forgetful and struggles to manage his finances. Additionally, his walking has become remarkably slow and unsteady; he walks with his feet spread apart and appears as if his shoes are 'stuck to the floor.' In the past month, he has had several episodes of urinary incontinence, which he seems largely unconcerned about. His medical history includes hypertension and osteoarthritis. Neurological examination reveals a wide-based, magnetic gait with short steps. Muscle strength and deep tendon reflexes are normal, and there is no resting tremor or cogwheel rigidity. Montreal Cognitive Assessment score is 21/3021/30. Which of the following is the most appropriate next step in the diagnostic workup?

Show answer & explanation

Answer: Magnetic resonance imaging of the brain

Answer

Magnetic resonance imaging of the brain
The correct answer is magnetic resonance imaging of the brain. This patient's presentation of cognitive impairment, a wide-based 'magnetic' gait, and urinary incontinence constitutes the classic triad of normal pressure hydrocephalus (NPH). The initial diagnostic step for suspected NPH is always structural neuroimaging (MRI or CT of the brain). This is essential to document ventriculomegaly out of proportion to cerebral atrophy and to rule out other structural etiologies before any invasive testing is attempted.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient exhibits a progressive triad of cognitive impairment, wide-based magnetic gait, and urinary incontinence.
Identifying symptom clusters is essential for accurate syndromic diagnosis in geriatrics.
2
Formulate a primary differential diagnosis based on the triad.
The combination of 'wacky, wobbly, and wet' is the classic presentation of normal pressure hydrocephalus (NPH).
This specific combination distinguishes NPH from other dementias like Alzheimer disease or vascular dementia.
3
Determine the safest and most appropriate initial diagnostic step.
Structural neuroimaging must be performed first.
Imaging confirms ventriculomegaly and rules out structural lesions, which is a prerequisite before performing invasive testing like a high-volume lumbar puncture.

Key Concept

Diagnostic evaluation algorithm for Normal Pressure Hydrocephalus
Question 50Question →

During a routine home-visit evaluation, a geriatric psychiatrist examines a 73-year-old man whose daughter reports a 9-month history of progressive cognitive decline and unusual behaviors. The daughter emphasizes that his mental clarity fluctuates dramatically; he can be highly alert in the morning but profoundly lethargic and disorganized by the afternoon. Over the past 3 months, he has started seeing "strangers sitting on the living room couch," which causes him significant distress and agitation. For the past 4 years, he has exhibited violent thrashing and shouting movements during sleep. His medical history is significant for major depressive disorder, for which he has taken fluoxetine continuously for the last 5 years. Vital signs are within normal limits. Neurologic examination demonstrates bilateral cogwheel rigidity and a mild resting tremor in the left upper extremity. His Montreal Cognitive Assessment score is 20/30, featuring prominent deficits in visuospatial construction. The physician discusses management options with the daughter to address the patient's distressing visual hallucinations. Which of the following is the most appropriate next step in the pharmacologic management of this patient's condition?

Show answer & explanation

Answer: Initiate a central acetylcholinesterase inhibitor

Answer

The correct answer is to initiate a central acetylcholinesterase inhibitor.
The correct answer involves initiating a central acetylcholinesterase inhibitor (such as rivastigmine or donepezil). This patient's presentation of progressive cognitive decline, prominent fluctuations in alertness, recurrent well-formed visual hallucinations, parkinsonism (rigidity, resting tremor), and REM sleep behavior disorder is the classic clinical triad/tetrad for Major Neurocognitive Disorder with Lewy Bodies (DLB). In patients with DLB, acetylcholinesterase inhibitors are considered the first-line pharmacotherapy. They effectively reduce the frequency and severity of visual hallucinations and improve cognitive fluctuations. Importantly, they achieve this without carrying the severe morbidity and mortality risks associated with antipsychotic medications in this specific patient population.

Step-by-Step Solution

1
Identify the primary underlying syndrome based on the clinical presentation.
The combination of fluctuating cognition, well-formed visual hallucinations, parkinsonism (rigidity, resting tremor), and REM sleep behavior disorder establishes a diagnosis of Major Neurocognitive Disorder with Lewy Bodies (DLB).
Accurate diagnosis is required because DLB has unique pharmacological sensitivities compared to other neurocognitive disorders.
2
Determine the primary goal of the requested intervention.
The patient requires management for distressing visual hallucinations and agitation.
Treatment should target the specific symptom causing the most distress while avoiding harm to the patient.
3
Select the safest and most effective initial pharmacotherapy for DLB.
Central acetylcholinesterase inhibitors (e.g., rivastigmine, donepezil) are the treatment of choice.
These medications safely improve both cognitive and neuropsychiatric symptoms (including hallucinations) in DLB without the severe risks associated with antipsychotics.
4
Evaluate the remaining options for dangerous drug interactions or contraindications.
Haloperidol is ruled out due to the risk of severe neuroleptic sensitivity in DLB; selegiline is ruled out due to the risk of Serotonin Syndrome when combined with the patient's current fluoxetine prescription.
Ruling out dangerous psychopharmacological interactions confirms the safety and necessity of the correct choice.

Key Concept

Major Neurocognitive Disorder with Lewy Bodies presents with fluctuating cognition, visual hallucinations, parkinsonism, and REM sleep behavior disorder; initial pharmacotherapy for cognitive and behavioral symptoms should utilize acetylcholinesterase inhibitors while strictly avoiding typical antipsychotics.
Question 51Question →

A primary care physician is evaluating a 71-year-old retired mechanic who is accompanied by his son. The son reports that over the past 14 months, his father has exhibited progressive short-term memory loss, missed several bill payments, and recently struggled to recall the names of his grandchildren. The patient feels he is "doing just fine" and is mildly annoyed by the visit. Vital signs are normal, and the neurological examination is nonfocal. Arrange the following diagnostic and management steps in the most appropriate chronological sequence for evaluating and managing this patient's suspected major neurocognitive disorder, from initial clinical assessment to definitive management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with objective cognitive screening, followed by screening for reversible metabolic causes, obtaining structural neuroimaging, considering specialized biomarker testing if indicated, and concluding with a comprehensive management and safety plan.
The standard of care for evaluating insidious cognitive decline follows a stepwise approach designed to minimize unnecessary testing while safely ruling out reversible etiologies. The clinician must first objectively confirm the cognitive deficit (Step 1). Subsequently, easily reversible systemic, endocrine, and metabolic causes are excluded via basic laboratory testing (Step 2). Once metabolic causes are ruled out, structural neuroimaging is obtained to identify vascular changes, space-occupying lesions, or distinct neurodegenerative atrophy patterns (Step 3). If the diagnosis remains equivocal, advanced functional imaging or cerebrospinal fluid biomarker testing may be considered (Step 4). Finally, once a diagnosis is established, a comprehensive management plan addressing safety, pharmacology, and long-term care is implemented (Step 5).

Step-by-Step Solution

1
Confirm cognitive impairment.
Use of the Montreal Cognitive Assessment or Mini-Mental State Examination.
Before pursuing a costly and potentially invasive diagnostic workup, the presence and severity of cognitive deficits must be objectively established.
2
Rule out reversible metabolic or systemic causes.
Ordering vitamin B12, TSH, comprehensive metabolic panel, and complete blood count.
Hypothyroidism, vitamin B12 deficiency, and various metabolic derangements can present as pseudodementia and are easily treatable if identified early.
3
Evaluate for structural intracranial pathology.
Performing a non-contrast brain MRI (or CT).
Structural imaging rules out space-occupying lesions, normal pressure hydrocephalus, and vascular dementia while evaluating for characteristic neurodegenerative atrophy patterns.
4
Differentiate complex or atypical etiologies.
Considering FDG-PET, amyloid PET, or lumbar puncture.
If the presentation is atypical (e.g., early-onset) or the distinction between Alzheimer disease and frontotemporal dementia is unclear, specialized biomarkers are utilized.
5
Establish long-term management and safety parameters.
Discussing driving cessation, advance directives, and prescribing medications like cholinesterase inhibitors.
Appropriate medical and social management is tailored based on the definitive diagnosis reached through the preceding diagnostic cascade.

Key Concept

Diagnostic Algorithm for Major Neurocognitive Disorders
Question 52Question →

A 76-year-old retired architect is brought to the clinic by his son. Over the past 88 months, the patient has experienced a progressive decline in his cognitive abilities. His son notes that the patient's alertness fluctuates significantly from day to day; he sometimes stares blankly for several minutes during conversations. The patient also frequently reports seeing unfamiliar children playing in his living room, though he is not distressed by their presence. His medical history includes major depressive disorder, for which he has taken fluoxetine for 55 years. Vital signs are within normal limits. Neurological examination reveals a resting tremor in the left hand, symmetric rigidity, and a slow, shuffling gait. The Montreal Cognitive Assessment (MoCA) score is 19/3019/30. Laboratory studies show:

Thyroid-stimulating hormone (TSH): 2.4 \muU/mL2.4 \text{ \mu U/mL} (normal: 0.4−4.0 \muU/mL0.4-4.0 \text{ \mu U/mL})
Free thyroxine (T4): 1.3 ng/dL1.3 \text{ ng/dL} (normal: 0.9−2.4 ng/dL0.9-2.4 \text{ ng/dL})

The son is overwhelmed by the recent changes and demands that his father be admitted to a locked psychiatric facility immediately. However, the patient's previously executed advance directive designates his wife as the healthcare proxy and expresses a clear preference for home-based care.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate rivastigmine therapy

Answer

The most appropriate next step is to initiate rivastigmine therapy.
This patient's clinical presentation—progressive cognitive decline, marked fluctuations in alertness, well-formed visual hallucinations, and spontaneous parkinsonism—is highly characteristic of major neurocognitive disorder with Lewy bodies (LBD). Cholinesterase inhibitors, such as rivastigmine, donepezil, or galantamine, are the first-line pharmacological treatment to manage the cognitive and behavioral symptoms of LBD. They effectively improve hallucinations, stabilize fluctuating cognition, and carry a lower risk of exacerbating motor symptoms compared to antipsychotics.

Step-by-Step Solution

1
Analyze the clinical presentation and timeline.
The patient has an 8-month history of progressive cognitive decline, marked fluctuations in alertness, well-formed visual hallucinations, and spontaneous parkinsonism (resting tremor, rigidity, shuffling gait).
Identifying the classic clinical triad establishes the diagnosis of Major Neurocognitive Disorder with Lewy bodies (LBD).
2
Evaluate the laboratory results and ethical context.
TSH and free T4 are within normal limits, ruling out primary hypothyroidism. The patient has a valid advance directive naming his wife as proxy and preferring home care, superseding the son's demands.
Ruling out reversible causes (like thyroid dysfunction) and respecting ethical guidelines are mandatory before initiating new therapies.
3
Determine the optimal pharmacological management for the confirmed diagnosis.
Rivastigmine, a central acetylcholinesterase inhibitor, is selected.
Cholinesterase inhibitors are the first-line evidence-based treatment for the cognitive and behavioral symptoms (including hallucinations) of LBD. Antipsychotics must be avoided due to severe neuroleptic sensitivity.

Key Concept

Major neurocognitive disorder with Lewy bodies (LBD) presents with fluctuating cognition, visual hallucinations, and parkinsonism; cholinesterase inhibitors are the preferred initial treatment for cognitive and neuropsychiatric symptoms.
Estimated Time:1m 30s
Question 53Question →

An 80-year-old man, a former university professor, visits his outpatient provider accompanied by his daughter. She expresses concern that over the past 18 months, he has been repeatedly misplacing important documents, forgetting appointments, and struggling to manage his finances. Last week, he was found wandering several blocks from his house, unable to remember the route back. Vital signs are stable, and the neurological examination shows no focal deficits. The provider plans a comprehensive evaluation and anticipates a long-term management strategy for presumed Alzheimer disease.

Arrange the following clinical steps in the appropriate chronological sequence for the standard diagnostic evaluation and progressive longitudinal management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with the objective quantification of the cognitive deficit, followed by ruling out secondary causes via labs and imaging, initiating first-line monotherapy for mild-to-moderate disease, escalating to combination therapy as the disease reaches the moderate-to-severe stage, and finally focusing on palliative and skilled care in the terminal stages.
The standard of care for evaluating and managing progressive memory loss follows a strict chronological pathway. First, the physician must objectively confirm the impairment using validated cognitive scales. Second, neuroimaging and laboratory tests must be obtained to exclude reversible causes such as hypothyroidism, neurosyphilis, B12 deficiency, or structural intracranial lesions. Only after a clinical diagnosis of major neurocognitive disorder (likely Alzheimer disease) is established should first-line pharmacotherapy with an acetylcholinesterase inhibitor (donepezil) be started. As the disease naturally progresses over years to a moderate-to-severe stage, the addition of an NMDA receptor antagonist (memantine) is indicated. Finally, in the late/terminal stages of the disease, when the patient is fully dependent and medications offer little to no functional benefit, the focus appropriately shifts toward skilled nursing and palliative care.

Step-by-Step Solution

1
Administer a cognitive screening tool (e.g., MoCA or MMSE).
Establishes the presence and severity of objective cognitive decline.
It is necessary to confirm that the patient's cognitive deficits are genuine and measurable before proceeding with an extensive medical workup.
2
Order screening labs (TSH, B12, CMP, CBC) and a noncontrast Head CT or Brain MRI.
Excludes potentially reversible causes of dementia.
Guidelines mandate ruling out metabolic disturbances, nutritional deficiencies, and structural lesions before diagnosing Alzheimer disease.
3
Start an acetylcholinesterase inhibitor (AChEI).
Provides symptomatic benefit for mild-to-moderate Alzheimer disease.
AChEIs (donepezil, rivastigmine, galantamine) are the standard first-line pharmacotherapy following a formal diagnosis.
4
Add memantine.
Augments therapy for advancing disease.
Memantine, an NMDA receptor antagonist, is indicated only when the patient's condition progresses from mild to moderate-to-severe Alzheimer disease.
5
Implement palliative care and skilled nursing transition.
Ensures safety and comfort in end-stage dementia.
When patients completely lose the ability to perform basic activities of daily living (ADLs) and require 24/7 care, the clinical focus shifts to custodial and palliative care.

Key Concept

Diagnostic algorithm and progressive pharmacological management of Alzheimer disease
Question 54Question →

Match the following clinical vignettes to the most likely underlying neurocognitive disorder etiology.

Click a left item, then click its matching right item

Items

A 75-year-old man presents with abrupt worsening of cognitive function followed by periods of stability, and asymmetric hyperreflexia on examination.
A 68-year-old woman exhibits socially inappropriate behaviors, loss of empathy, and a new habit of consuming large amounts of sweets, with intact navigation skills.
A 78-year-old man experiences fluctuating alertness, detailed visual hallucinations of animals, and violent movements during sleep, alongside new-onset parkinsonism.
A 74-year-old woman displays a gradual, progressive decline in episodic memory and gets lost in her own neighborhood, with no focal motor deficits.
An 80-year-old man develops a 'magnetic' wide-based gait, urinary urgency, and prominent psychomotor slowing over several months.

Matches

Show answer & explanation

Answer

Vignette 1 maps to Vascular dementia, Vignette 2 maps to Frontotemporal dementia, Vignette 3 maps to Dementia with Lewy bodies, Vignette 4 maps to Alzheimer disease, and Vignette 5 maps to Normal pressure hydrocephalus.
Each neurocognitive disorder has a distinct initial clinical presentation. Alzheimer disease presents with insidious memory loss. Frontotemporal dementia presents with early personality and behavioral changes. Lewy body dementia is characterized by visual hallucinations, parkinsonism, and fluctuating cognition. Vascular dementia shows a step-wise decline with focal neurological deficits. Normal pressure hydrocephalus presents with the classic triad of gait apraxia, urinary incontinence, and dementia.

Step-by-Step Solution

1
Analyze the first vignette for the pattern of decline and presence of neurologic signs.
Identified a step-wise progression and focal neurologic deficits.
These are hallmark features of a vascular etiology due to sequential ischemic events.
2
Evaluate the second vignette for predominant early symptoms.
Identified prominent behavioral changes and hyperorality overshadowing memory loss.
Behavioral disinhibition is the core diagnostic criterion for frontotemporal lobar degeneration.
3
Review the third vignette for characteristic symptom triads.
Recognized the combination of visual hallucinations, parkinsonism, and REM sleep behavior disorder.
This combination is highly specific for an alpha-synucleinopathy with Lewy bodies.
4
Assess the fourth vignette for onset speed and the domain of impairment.
Noted an insidious onset of purely episodic memory and visuospatial deficits.
This represents the typical amnestic presentation of Alzheimer disease.
5
Examine the fifth vignette for a classic symptom triad.
Identified the 'wobbly, wet, and wacky' triad.
This constellation is pathognomonic for idiopathic normal pressure hydrocephalus.

Key Concept

Differentiation of major neurocognitive disorders based on core clinical features and initial presentation.
Estimated Time:1m 30s
Question 55Question →

A 6868-year-old man is brought to the emergency department by his wife due to severe muscle stiffness, fever, and marked confusion over the past 4848 hours. Over the past 1414 months, the patient has experienced progressive cognitive decline, prominent day-to-day fluctuations in alertness, and vivid, recurrent visual hallucinations of people in his house. His wife notes that he often thrashes and punches his pillows while asleep. His past medical history is significant for major depressive disorder. Current medications include a daily multivitamin and citalopram. Three days ago, a covering physician prescribed haloperidol to manage the patient's distressing hallucinations. On examination, his temperature is 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), pulse is 118 /min118\text{ /min}, and blood pressure is 168/102 mm Hg168/102\text{ mm Hg}. He is diaphoretic and disoriented. Neurologic examination reveals profound "lead-pipe" muscle rigidity in all extremities. Deep tendon reflexes are 1+1+ bilaterally, and there is no clonus. Laboratory studies show a creatine kinase of 4,500 U/L4,500\text{ U/L}, a TSH of 3.5 mU/L3.5\text{ mU/L} (normal: 0.5−5.0 mU/L0.5-5.0\text{ mU/L}), and a free T4 of 1.2 ng/dL1.2\text{ ng/dL} (normal: 0.9−1.7 ng/dL0.9-1.7\text{ ng/dL}). Which of the following is the most likely cause of this patient's acute presentation?

Show answer & explanation

Answer: Extreme sensitivity to dopamine antagonism

Answer

Extreme sensitivity to dopamine antagonism
The patient's 14-month history of fluctuating cognition, recurrent visual hallucinations, and REM sleep behavior disorder is the classic triad for Major Neurocognitive Disorder with Lewy Bodies (LBD). A key clinical feature of LBD is severe sensitivity to dopamine antagonists (particularly typical antipsychotics like haloperidol). Administering these medications to a patient with LBD can rapidly precipitate Neuroleptic Malignant Syndrome (NMS). NMS is a life-threatening neurologic emergency characterized by the tetrad of altered mental status, autonomic instability (fever, tachycardia, hypertension), 'lead-pipe' muscle rigidity, and elevated creatine kinase. Therefore, extreme sensitivity to dopamine antagonism is the underlying cause of this patient's acute deterioration.

Step-by-Step Solution

1
Diagnose the underlying neurocognitive disorder based on the 14-month history.
The combination of progressive cognitive decline, fluctuating alertness, visual hallucinations, and REM sleep behavior disorder strongly points to Major Neurocognitive Disorder with Lewy Bodies (LBD).
Establishing the correct type of dementia is crucial for understanding medication contraindications.
2
Analyze the recent medication change and its interaction with the underlying disease.
The patient was recently prescribed haloperidol, a typical antipsychotic (dopamine antagonist).
Patients with LBD have a well-documented, severe sensitivity to neuroleptic medications.
3
Evaluate the acute clinical signs and laboratory findings.
Fever, tachycardia, hypertension, diaphoresis, extreme 'lead-pipe' rigidity, normal/decreased reflexes, and significantly elevated creatine kinase indicate Neuroleptic Malignant Syndrome (NMS).
The clinical picture perfectly matches NMS, which was precipitated by the administration of a dopamine antagonist in a highly susceptible LBD patient.

Key Concept

Patients with Lewy Body Dementia exhibit severe sensitivity to typical antipsychotics (dopamine antagonists), which can rapidly precipitate potentially fatal Neuroleptic Malignant Syndrome (NMS).
Estimated Time:1m 30s
Question 56Question →

An 82-year-old man with a history of mild Alzheimer dementia is hospitalized for a urinary tract infection. On hospital day 2, he becomes acutely agitated, disoriented, and begins pulling at his intravenous lines. He is experiencing visual hallucinations and yelling at the nursing staff. Arrange the following interventions in the most appropriate sequential order of escalation, from initial best practices to interventions of absolute last resort, for the management of this patient's acute delirium with severe agitation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of clinical escalation is: 1) Identify and treat the underlying medical precipitants, 2) Implement nonpharmacologic environmental interventions, 3) Administer a short-acting, low-dose antipsychotic for refractory agitation, and 4) Apply physical restraints as a temporary measure of absolute last resort.
The correct sequence reflects the standard of care for delirium. The definitive treatment is treating the underlying cause (infection). While the medical workup and treatment are underway, nonpharmacologic interventions are the safest and most effective first-line strategy to manage symptoms. Pharmacologic restraints (antipsychotics) are a second-line symptomatic treatment for severe, dangerous agitation. Physical restraints are the most restrictive and dangerous intervention, reserved as an absolute last resort.

Step-by-Step Solution

1
Establish the diagnosis and the primary therapeutic goal.
The patient is experiencing hyperactive delirium secondary to a urinary tract infection. The primary goal is reversing the underlying physiologic trigger.
Delirium is a manifestation of systemic illness, not a primary psychiatric disorder. Reversing the cause is the only definitive treatment.
2
Determine the first-line symptomatic management for the behavioral disturbances.
Nonpharmacologic environmental interventions are prioritized.
These measures (e.g., reorientation, minimizing tethers, promoting sleep) reduce confusion safely without the adverse effects associated with medications.
3
Identify the threshold for escalating to pharmacologic therapy.
Antipsychotics are considered only if the agitation becomes dangerous.
Medications like haloperidol do not treat the underlying delirium and can worsen outcomes; they are reserved strictly for patients who fail nonpharmacologic measures and pose an imminent danger to themselves or others.
4
Identify the absolute last resort intervention.
Physical restraints are considered.
Restraints exacerbate delirium, increase agitation, and risk physical injury. They are only used temporarily when all other options have been exhausted to prevent the life-threatening disruption of medical care.

Key Concept

The management of acute delirium follows a strict stepwise escalation: identify and treat the underlying cause, maximize nonpharmacologic interventions, reserve antipsychotics for severe/dangerous agitation, and use physical restraints strictly as a temporary last resort.
Question 57Question →

During a specialized memory disorders conference, a panel of neurologists and psychiatrists discusses five complex patient cases to highlight the diverse pathophysiology of neurodegenerative conditions. For each patient vignette described below, identify and match the correct specific neurocognitive disorder diagnosis.

Click a left item, then click its matching right item

Items

A 71-year-old man who developed vivid hallucinations of small animals and episodic blank stares one year after beginning to physically act out his dreams.
A 59-year-old woman demonstrating new-onset shoplifting, profound apathy, and a compulsion to eat exclusively sweets, while maintaining a score of 27 out of 30 on a cognitive exam.
A 76-year-old man with uncontrolled hypertension who suffered a sudden decline in executive function three months ago that has since plateaued, presenting with asymmetric deep tendon reflexes.
A 75-year-old man with a 10-year established history of asymmetric resting tremor and bradykinesia, who now presents with insidious memory retrieval deficits that improve with cueing.
A 78-year-old woman with a 3-year history of progressive inability to retain new information, severe anomia, and getting lost in her own neighborhood, with a normal motor examination.

Matches

Show answer & explanation

Answer

The correct pairings successfully match the hallmark clinical manifestations and temporal disease progression to their respective specific neurocognitive etiologies.
Each neurocognitive disorder presents with a distinct temporal pattern and clinical phenotype. Lewy body disease is characterized by early hallucinations and REM sleep behavior disorder. Frontotemporal disease initially spares memory while profoundly altering personality and behavior. Vascular disease presents in a step-wise fashion correlating with cerebrovascular events. Parkinson disease dementia occurs in the context of long-standing established motor symptoms. Alzheimer disease typically begins with insidious episodic memory and language deficits without early prominent motor signs.

Step-by-Step Solution

1
Analyze the first patient case for diagnostic triad features.
Identified REM sleep behavior disorder, fluctuating cognition, and visual hallucinations.
These are the consensus diagnostic criteria for Lewy body dementia, which often precedes or coincides with Parkinsonism.
2
Evaluate the second patient case for early psychiatric or behavioral changes.
Identified prominent disinhibition, apathy, and hyperorality with spared formal memory testing.
These features define the behavioral variant of frontotemporal dementia, distinguishing it from primary memory disorders.
3
Assess the third patient case for temporal progression and associated signs.
Identified a step-wise, sudden decline correlating with focal neurological signs and vascular risk factors.
This pattern is highly indicative of vascular neurocognitive disorder caused by cerebrovascular disease.
4
Review the fourth patient case for symptom timeline relative to motor symptoms.
Noted cognitive decline occurring 10 years after the onset of well-established Parkinsonian motor symptoms.
The '1-year rule' differentiates Parkinson disease dementia from Lewy body dementia; cognitive symptoms must emerge well after established motor symptoms in the former.
5
Examine the fifth patient case for the primary domain of cognitive impairment.
Identified early and prominent episodic memory impairment, language deficits, and intact motor function.
This insidious amnestic presentation is the classic progression of Alzheimer disease.

Key Concept

Distinct clinical presentations, particularly the chronological sequence of cognitive, behavioral, and motor symptoms, differentiate the major neurocognitive disorders.
Question 58Question →

A 58-year-old man is brought to the physician by his wife due to profound changes in his behavior over the past 12 months. His wife states that he was previously a reserved and empathetic middle school teacher, but he recently began making sexually explicit comments to strangers at the grocery store. He has also developed a habit of eating exclusively sugary cereals and frequently takes food from the plates of other patrons at restaurants. When confronted about these actions, the patient is apathetic and demonstrates no remorse. His medical history is significant for hyperlipidemia. Vital signs are within normal limits. On mental status examination, he is alert and oriented to person, place, and time. He scores 26/30 on the Montreal Cognitive Assessment, primarily losing points on verbal fluency and abstraction. Memory recall is intact. Neurological examination reveals a positive grasp reflex but is otherwise unremarkable. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Frontotemporal dementia

Answer

Frontotemporal dementia
The correct answer is frontotemporal dementia. This patient's presentation of early-onset personality changes, marked disinhibition (making sexually explicit comments), apathy, hyperorality (exclusive diet of sugary cereals, taking food from others), and relative sparing of memory is highly characteristic of the behavioral variant of frontotemporal dementia (bvFTD). The presence of frontal release signs (such as a positive grasp reflex) further supports frontal lobe dysfunction. Memory is classically preserved early in the disease, whereas executive dysfunction (impaired verbal fluency and abstraction) is prominent.

Step-by-Step Solution

1
Identify the primary clinical manifestations in the vignette.
The patient has early-onset personality changes, marked disinhibition, apathy, hyperorality, and frontal release signs.
Recognizing the core symptoms is essential for differentiating neurocognitive disorders.
2
Evaluate the patient's cognitive profile.
The patient has intact memory recall and orientation but exhibits executive dysfunction (poor verbal fluency and abstraction).
The pattern of cognitive deficits helps rule out memory-predominant dementias like Alzheimer disease.
3
Synthesize the behavioral and cognitive findings to determine the diagnosis.
The combination of severe behavioral variant symptoms with executive dysfunction and spared memory strongly indicates frontotemporal dementia.
These findings strictly meet the clinical diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD).

Key Concept

The behavioral variant of frontotemporal dementia presents with early and prominent personality changes, disinhibition, apathy, hyperorality, and executive dysfunction, with relative sparing of memory and visuospatial skills.
Question 59Question →

Match each patient's clinical presentation with the most likely corresponding neuroimaging or ancillary diagnostic finding.

Click a left item, then click its matching right item

Items

A 75-year-old woman is evaluated for a 3-year history of worsening short-term memory, increasing difficulty naming familiar objects, and recently getting lost while driving in her own neighborhood.
A 61-year-old man is brought in by his daughter due to a 1-year history of progressive social disinhibition, profound apathy, and a newly developed compulsion to consume entire boxes of sweets.
A 65-year-old woman is admitted for a 3-month history of rapidly progressive cognitive decline, frequently exhibiting startle myoclonus and recently progressing to akinetic mutism.
A 72-year-old man presents with a 6-month history of cognitive slowing, a wide-based 'glued to the floor' gait, and episodic urinary incontinence.

Matches

Show answer & explanation

Answer

The presentations match as follows: Insidious memory loss (Alzheimer disease) matches medial temporal atrophy. Early behavioral changes (Frontotemporal dementia) matches frontal and temporal atrophy. Rapid decline with myoclonus (Creutzfeldt-Jakob disease) matches basal ganglia hyperintensity. Gait apraxia with incontinence (Normal pressure hydrocephalus) matches ventriculomegaly out of proportion to sulcal widening.
Each clinical presentation contains classic diagnostic clues for specific neurocognitive disorders. Insidious memory loss points to Alzheimer disease (medial temporal atrophy). Early personality changes and hyperorality point to frontotemporal dementia (frontal/temporal atrophy). Rapid decline with myoclonus points to Creutzfeldt-Jakob disease (DWI cortical ribboning). The classic 'wobbly, wacky, wet' triad points to normal pressure hydrocephalus (disproportionate ventriculomegaly).

Step-by-Step Solution

1
Identify the underlying neurocognitive syndrome described in each clinical vignette based on the timeline and primary symptoms.
The vignettes represent Alzheimer disease, behavioral variant frontotemporal dementia, Creutzfeldt-Jakob disease, and normal pressure hydrocephalus, respectively.
Accurate syndromic diagnosis is the prerequisite for anticipating the expected diagnostic or pathological findings.
2
Correlate each identified neurocognitive disorder with its characteristic neuroimaging findings.
Alzheimer disease is paired with medial temporal atrophy; frontotemporal dementia with focal frontal/temporal atrophy; Creutzfeldt-Jakob disease with cortical ribboning on DWI; and normal pressure hydrocephalus with disproportionate ventriculomegaly.
While definitive diagnosis of most dementias requires histopathology, distinct structural and functional imaging patterns strongly support specific clinical diagnoses.

Key Concept

Correlation of distinct clinical syndromes in major neurocognitive disorders with their hallmark neuroimaging patterns.
Question 60Question →

Pair the following clinical presentations with the most likely corresponding neurocognitive disorder.

Click a left item, then click its matching right item

Items

A 67-year-old executive exhibits new-onset apathy, declining personal hygiene, and inappropriately sexually suggestive comments to staff, with relatively preserved memory and visuospatial skills.
A 71-year-old mechanic develops recurrent, detailed visual hallucinations of animals, fluctuating periods of profound confusion, and a rigid, slow, shuffling gait.
A 76-year-old retired nurse presents with a broad-based, magnetic gait, new-onset involuntary leakage of urine, and recent psychomotor retardation with cognitive slowing.
A 69-year-old accountant with poorly controlled hypertension shows a sudden, stepwise decline in executive function three months after an episode of transient right-sided weakness.

Matches

Show answer & explanation

Answer

The presentations map respectively to frontotemporal dementia (early behavior changes and disinhibition), dementia with Lewy bodies (visual hallucinations and parkinsonism), normal pressure hydrocephalus (classic triad of gait disturbance, incontinence, and dementia), and vascular dementia (stepwise decline following a cerebrovascular event).
Each clinical presentation contains classic pathognomonic features that align with specific diagnostic criteria for the major neurocognitive disorders, allowing clear differentiation between them.

Step-by-Step Solution

1
Analyze the 67-year-old executive's presentation.
Identified early behavioral changes, disinhibition, and preserved memory.
These features distinguish behavioral variant frontotemporal dementia from Alzheimer disease, where memory loss is typically the first prominent symptom.
2
Evaluate the 71-year-old mechanic's symptoms.
Noted recurrent visual hallucinations, cognitive fluctuations, and parkinsonism.
This specific clinical triad forms the core diagnostic criteria for dementia with Lewy bodies.
3
Assess the 76-year-old retired nurse's clinical signs.
Recognized the triad of magnetic gait, incontinence, and cognitive decline.
This triad is classic for normal pressure hydrocephalus and indicates a potentially reversible cause of dementia.
4
Review the 69-year-old accountant's history.
Correlated the stepwise cognitive decline with a history of hypertension and a prior transient ischemic attack.
A sudden onset and stepwise progression of cognitive impairment following focal neurologic deficits point to vascular neurocognitive disorder.

Key Concept

Differential diagnosis of major neurocognitive disorders based on core clinical criteria and timeline of symptom onset.
PreviousPage 3 / 4Next
Neurocognitive Disorders Practice Questions — USMLE Step 2 CK — Page 3 | Examkin